Long-Term Safety of Ontamalimab in Patients with Moderate to Severe Inflammatory Bowel Disease
- DOI
- 10.2147/ceg.s618654
- Published
- 2026-10
- Container
- Clinical and Experimental Gastroenterology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2147/ceg.s618654,
title = {Long-Term Safety of Ontamalimab in Patients with Moderate to Severe Inflammatory Bowel Disease},
author = {Geert D'Haens and Séverine Vermeire and Walter Reinisch and Silvio Danese and William J Sandborn and Stefan Schreiber and Stephen Hanauer and Caleb Bliss and Fabio Cataldi and Martina Goetsch and Kenneth J Gorelick and Michelle Mendoza and Péter Nagy},
year = {2026},
journal = {Clinical and Experimental Gastroenterology},
doi = {10.2147/ceg.s618654},
url = {https://doi.org/10.2147/ceg.s618654}
}RIS
TY - JOUR TI - Long-Term Safety of Ontamalimab in Patients with Moderate to Severe Inflammatory Bowel Disease AU - Geert D'Haens AU - Séverine Vermeire AU - Walter Reinisch AU - Silvio Danese AU - William J Sandborn AU - Stefan Schreiber AU - Stephen Hanauer AU - Caleb Bliss AU - Fabio Cataldi AU - Martina Goetsch AU - Kenneth J Gorelick AU - Michelle Mendoza AU - Péter Nagy PY - 2026 JO - Clinical and Experimental Gastroenterology DO - 10.2147/ceg.s618654 UR - https://doi.org/10.2147/ceg.s618654 ER -
APA
D'Haens, G., Vermeire, S., Reinisch, W., Danese, S., Sandborn, W. J., Schreiber, S., Hanauer, S., Bliss, C., Cataldi, F., Goetsch, M., Gorelick, K. J., Mendoza, M., & Nagy, P. (2026). Long-Term Safety of Ontamalimab in Patients with Moderate to Severe Inflammatory Bowel Disease. Clinical and Experimental Gastroenterology. https://doi.org/10.2147/ceg.s618654
Source records
- crossref · retrieved 2026-11-05T20:31:20.263Z